High-Throughput Screening for the Discovery of Enzyme Inhibitors

被引：56

作者：

Lloyd, Matthew D. ^{[1
]}

机构：

[1] Univ Bath, Dept Pharm & Pharmacol, Drug & Target Dev, Bath BA2 7AY, Avon, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 63卷 / 19期

关键词：

PHOSPHODIESTERASE 2A INHIBITOR; TYPE-1; REVERSE-TRANSCRIPTASE; TARGET RESIDENCE TIME; SELECTIVE INHIBITORS; DRUG DISCOVERY; ASSAY INTERFERENCE; MYCOBACTERIUM-TUBERCULOSIS; ALLOSTERIC INHIBITORS; PLASMODIUM-FALCIPARUM; COLORIMETRIC ASSAY;

D O I：

10.1021/acs.jmedchem.0c00523

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Enzymes are common targets in high-throughput screening and related campaigns. An analysis of papers published between 1990 and 2018 showed that kinases were the most common enzymes investigated, fluorescence-based assays were the most common readout method, and cancer and bacterial infections were the most common therapeutic areas. High-throughput screening and fragment-screening campaigns published between 2017 and 2019 were analyzed in more depth, giving 75 examples of hit to lead development. Kinases, phosphatases, proteases, and peptidases were the most common targets, fluorescent assays were the most commonly used, and a wide variety of structural features were observed within the derived drugs. Hit frequency was largely independent of library size and positively correlated with Z' value for the assay. Binding of metal ions to library compounds and substrates is an underappreciated source of false-positive results and unreproducible behavior.

引用

页码：10742 / 10772

页数：31

共 252 条

[1] Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA) [J].

Abdeen, Sanofar ;

Kunkle, Trent ;

Salim, Nilshad ;

Ray, Anne-Marie ;

Mammadova, Najiba ;

Summers, Corey ;

Stevens, Mckayla ;

Ambrose, Andrew J. ;

Park, Yangshin ;

Schultz, Peter G. ;

Horwich, Arthur L. ;

Hoang, Quyen Q. ;

Chapman, Eli ;

Johnson, Steven M. .

JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) :7345-7357

[2] Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma [J].

af Rosenschold, Magnus Munck ;

Johannesson, Petra ;

Nikitidis, Antonios ;

Tyrchan, Christian ;

Chang, Hui-Fang ;

Ronn, Robert ;

Chapman, Dave ;

Ullah, Victoria ;

Nikitidis, Grigorios ;

Glader, Pernilla ;

Kack, Helena ;

Bonn, Britta ;

Wagberg, Fredrik ;

Bjorkstrand, Eva ;

Andersson, Ulf ;

Swedin, Linda ;

Rohman, Mattias ;

Andreasson, Theresa ;

Bergstrom, Eva Lamm ;

Jiang, Fanyi ;

Zhou, Xiao-Hong ;

Lundqvist, Anders J. ;

Malmberg, Anna ;

Ek, Margareta ;

Gordon, Euan ;

Pettersen, Anna ;

Ripa, Lena ;

Davis, Andrew M. .

JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) :7769-7787

[3] Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors [J].

Aida, Jumpei ;

Fushimi, Makoto ;

Kusumoto, Tomokazu ;

Sugiyama, Hideyuki ;

Arimura, Naoto ;

Ikeda, Shuhei ;

Sasaki, Masako ;

Sogabe, Satoshi ;

Aoyama, Kazunobu ;

Koike, Tatsuki .

JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (20) :9205-9217

[4] Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation [J].

Albers, Harald M. H. G. ;

Dong, Anping ;

van Meeteren, Laurens A. ;

Egan, David A. ;

Sunkara, Manjula ;

van Tilburg, Erica W. ;

Schuurman, Karianne ;

van Tellingen, Olaf ;

Morris, Andrew J. ;

Smyth, Susan S. ;

Moolenaar, Wouter H. ;

Ovaa, Huib .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (16) :7257-7262

[5] The Ecstasy and Agony of Assay Interference Compounds [J].

Aldrich, Courtney ;

Bertozzi, Carolyn ;

Georg, Gunda I. ;

Kiessling, Laura ;

Lindsley, Craig ;

Liotta, Dennis ;

Merz, Kenneth M., Jr. ;

Schepartz, Alanna ;

Wang, Shaomeng .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) :2165-2168

[6]

[Anonymous], 2014, Perspectives in Science

[7] Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes [J].

Bachovchin, Daniel A. ;

Brown, Steven J. ;

Rosen, Hugh ;

Cravatt, Benjamin F. .

NATURE BIOTECHNOLOGY, 2009, 27 (04) :387-394

[8] New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays [J].

Baell, Jonathan B. ;

Holloway, Georgina A. .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) :2719-2740

[9] Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors [J].

Bagdanoff, Jeffrey T. ;

Chen, Zhouliang ;

Acker, Michael ;

Chen, Ying-Nan ;

Chan, Homan ;

Dore, Michael ;

Firestone, Brant ;

Fodor, Michelle ;

Fortanet, Jorge ;

Hentemann, Murphy ;

Kato, Mitsunori ;

Koenig, Robert ;

LaBonte, Laura R. ;

Liu, Shumei ;

Mohseni, Movarid ;

Ntaganda, Rukundo ;

Sarver, Patrick ;

Smith, Troy ;

Sendzik, Martin ;

Stams, Travis ;

Spence, Stan ;

Towler, Christopher ;

Wang, Hongyun ;

Wang, Ping ;

Williams, Sarah L. ;

LaMarche, Matthew J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) :1781-1792

[10] High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase [J].

Baldwin, J ;

Michnoff, CH ;

Malmquist, NA ;

White, J ;

Roth, MG ;

Rathod, PK ;

Phillips, MA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) :21847-21853

← 1 2 3 4 5 6 7 8 9 10 →